NervGen Pharma Corp. (NGEN)

NASDAQ

$1.53

$-0.01

(-0.91%)

Pre-Market

NervGen Pharma Corp. (NGEN) Live Price Chart

Last updated: ⁦2026-10-20 11:54:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

NervGen Pharma Corp. (NGEN) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.53, with a market capitalization of $170.96M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.53 to $6.30. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$170.96M
Open	$1.54
Day's High	$14.95
Day's Low	$0.05
Previous Close	$1.54
Volume	2.97K
Average Volume	502.40K
P/E Ratio	--
52-Week High	$6.30
52-Week Low	$1.53
Dividend Yield	--
Earnings Date	--

NervGen Pharma Corp. (NGEN) Pre-Market Stock Price

NervGen Pharma Corp. (NGEN) is trading at $1.53 in pre-market trading as of 2026-10-20 11:28:00, down 0.84% ($0.01) from the previous close of $1.54

Pre-market trading shows how investors are pricing NGEN before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

NervGen Pharma Corp. (NGEN) 7-Day Stock Price Change

Over the past seven days, NervGen Pharma Corp. (NGEN) moved from $1.73 to $1.53, representing a decline of 11.73% ($0.20).

The stock traded between $1.53 and $1.80 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 515.18 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

NGEN 52-Week Price Position

Position in Range: 0.0%

52W Low$1.53

52W High$6.30

NGEN is currently trading at $1.53, placing it 0.0% of the way from its 52-week low of $1.53 to its 52-week high of $6.30. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is NervGen Pharma Corp. (NGEN)?

NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.

NervGen Pharma Corp. Information

Employees	9
Exchange	NASDAQ
Company Website	https://www.nervgen.com

How to Buy NervGen Pharma Corp. (NGEN) Stock on MEXC

Eligible investors can buy real shares of NervGen Pharma Corp. (NGEN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NGEN and Place Your Order

Open the RealStocks trading page and search for NGEN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is NervGen Pharma Corp. (NGEN) stock price today?

NervGen Pharma Corp. (NGEN) is currently trading at $ 1.53, down 0.84% ($0.01) from the previous close of $ 1.54. Intraday prices update in real time during regular trading hours.

2.Is NGEN stock going up or down today?

As of 2026-10-20 11:28:00, NGEN is trading at $ 1.53, down 0.84% ($0.01) from its previous close of $ 1.54. The stock has traded between $ 0.05 and $ 14.95 during today’s regular session. Past price movements do not guarantee future results.

3.What is NGEN pre-market price?

As of 2026-10-20 11:28:00, NGEN is trading at $ 1.53 in pre-market trading, down 0.84% ($0.01) from the previous close of $ 1.54. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NGEN after-hours price?

As of 2026-10-20 11:28:00, NGEN is trading at $ 1.54 in after-hours trading, down 0.32% ($0.01) from the regular-session close of $ 1.54. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NGEN stock trading now?

NGEN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NGEN sit relative to its 52-week high and low?

Over the past 52 weeks, NGEN has traded between a low of $ 1.53 and a high of $ 6.30. At $ 1.53, the stock is positioned 0.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is NervGen Pharma Corp. in?

NervGen Pharma Corp. (NGEN) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is NervGen Pharma Corp.'s market capitalization and where is it listed?

NervGen Pharma Corp. is listed on the NASDAQ exchange with a market capitalization of $ 170.96M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NGEN valued in terms of P/E ratio and EPS?

NGEN trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does NervGen Pharma Corp. pay a dividend?

NervGen Pharma Corp. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.